| A cross-country comparison of reimbursed orphan medicines in Bulgaria, Greece and Romania M Kamusheva, A Stoimenova, M Doneva, A Zlatareva, G Petrova Biotechnology & Biotechnological Equipment 27 (5), 4186-4192, 2013 | 13 | 2013 |
| Analysis of access to orphan drugs in five neighboring European countries—Bulgaria, Greece, Macedonia, Romania and Serbia A Zlatareva, D Lakic, M Kamusheva, D Spaskov, M Georgi, P Guenka World Journal of Pharmacy and Pharmaceutical Sciences 2 (6), 4415-34, 2013 | 7 | 2013 |
| Analysis of the Reimbursement Policy in Central and Eastern European Countries: The Policy of Poland, Romania, Hungary and the Czech Republic, Part II A Zlatareva World J Pharm Pharm Sci 4 (9), 64-76, 2015 | 3 | 2015 |
| Modelling the financial framework of the pharmacotherapy cost of rare diseases with orphan medicines—part II A Zlatareva, K Tachkov, M Stoicheva, S Georgieva, MK Bozhkova, ... Modern Economy 2014, 2014 | 3 | 2014 |
| Financial analysis of the access to pharmacotherapy for rare diseases in Bulgaria A Zlatareva, K Tachkov, M Stoicheva, S Georgieva, G Momekov, ... Modern Economy 2014, 2014 | 3 | 2014 |
| Lifelong vaccination model: for a better quality of life R Argirova, A Zlatareva Biotechnology & Biotechnological Equipment 37 (1), 24-33, 2023 | 1 | 2023 |
| National health insurance fund cost analysis for rare cancer diseases and orphan drugs. A Zlatareva, G Petrova Obsha Meditsina/General Medicine 17 (1), 13-18, 2015 | 1 | 2015 |
| STUDY THE CARDIOLOGISTS'KNOWLEDGE AND PERCEPTION ABOUT GENERIC AND FIXED DOSE COMBINATION MEDICINES IN CARDIOLOGY Z Mitkova, P Milushewa, A Zlatareva, M Manova, K Tachkov, G Petrova Pharmacia 62 (4), 22-29, 2015 | 1 | 2015 |
| Markers of systemic inflammation and efficacy of immune therapy in patients with metastatic lung cancer. A literature review T Zlatanova, J Arabadjiev, A Zlatareva Scripta Scientifica Salutis Publicae 8 (1), 2022 | | 2022 |
| Antimicrobial resistance–causes, threats, solutions R Argirova, A Zlatareva World Journal of Biology Pharmacy and Health Sciences 12 (1), 041-047, 2022 | | 2022 |
| Comparative analysis of awareness of medical professionals in three Balkan countries (Bulgaria, Croatia, and Slovenia) of continuing education of medical professionals in the … B Brankov, A Zlatareva Folia Medica 63 (5), 786-796, 2021 | | 2021 |
| Pharmaceutical policy and public health in the eu candidate countries of the Western Balkans region A Zlatareva, B Brankov Health Economics and Management 19 (4), 22-36, 2021 | | 2021 |
| Healthcare and economy: Increasing investments in the healthcare for a better local economy A Zlatareva Health Economics and Management 19 (4), 3-9, 2021 | | 2021 |
| Non medication treatment of rosacea. K Krahtova, K Nastev, A Zlatareva | | 2017 |
| Low intensity laser light in the treatment of rosacea and acne (literature review). K Krahtova, K Nastev, A Zlatareva | | 2017 |
| The Cost of Oncology Medicines A Zlatareva, K Krahtova, T Kazak Acta Medica Bulgarica 44 (1), 22-29, 2017 | | 2017 |
| THE CONTROL ON EXPENSES FOR REIMBURSED DRUGS AND EXAMPLES OF MOST COMMONLY USED MEASURES AND POLICIES-THEORETICAL ANALYSIS (PART II) A ZLATAREVA GENERAL MEDICINE Учредители: Meditsinski Universitet-Sofia 18 (1), 14-19, 2016 | | 2016 |
| BENEFITS AND RISKS IN CONDUCTING OF CLINICAL TRIALS OF DRUGS IN HUMAN MEDICINE A Zlatareva | | 2015 |
| COMPARATIVE ANALYSIS OF THE MEDICINES REIMBURSEMENT MODELS IN ITALY, FRANCE, UNITED KINGDOM, AND GERMANY A Zlatareva | | 2015 |
| Stages of the policy of human rights, particularly the rights of patients. A Zlatareva Meditsinski Pregled/Medical Review 51 (6), 61-66, 2015 | | 2015 |
